Objective: The aim of the study was to investigate folate and other selected vitamin status (ascorbic acid, tocopherol, retinol, vitamin B 12 ), haematological indices and total homocysteine concentration of serum in women of childbearing age. Design: A cross-sectional study. Setting: Warsaw. Subjects: Healthy women aged 18 -30 y (n ¼ 78) not pregnant presently or previously, and not taking drugs. Results: Haemoglobin and haematocrit values according to WHO criteria for 18 to 30-y-old women were normal. The optimal levels of serum tocopherol, >1.29 mg=dl (>29.9 mmol=l) to preventing civilization diseases, were found in 5.5% and serum retinol >71.6 mcg=dl (>2.5 mmol=l) in 6.4% of all studied persons. The analysis of serum folate concentration showed high-risk deficiency,<3 ng=ml (<6.8 nmol=l), in 6.4%, moderate and low risk together (7.0 -14.9 nmol=l) in 61.6% and optimal folate levels (>14.9 nmol=l) in 32.0% of the studied group. Folate body stores were insufficient in almost all women. There was no high or moderate deficiency risk of vitamin B 12 or ascorbic acid. None of the women under study had serum total homocysteine (tHcy) concentration >15 mmol=l, indicating hyperhomocysteinaemia. Serum total homocysteine concentrations in the range of 5 -15 mmol=l were found in 71.8%, and serum tHcy >10 mmol=l in 7.7% of the studied group of women. Sponsorship: The study was sponsored by the Polish Committee for Scientific Research. Descriptors: folates serum and red blood cells; serum vitamin B 12 ; antioxidant vitamins (ascorbic acid, tocopherol, retinol); total homocysteine; women of childbearing age
Introduction
The role of nutrition in good health maintenance and disease prevention is proven. In recent years great attention has been focused on the role of folates and antioxidant vitamins in clinical and public health (Hennekenes, 1994; Ambrosi et al, 1998; Grimble, 1997; Pietrzik & Brönstrup, 1997a; Lyle et al, 1999; Palacios et al, 1999) . Suboptimal maternal folate status may be a cause of neural tube defects (NTD) in newborns, such as spina bifida or anencephaly, and is perhaps a risk factor for Down syndrome (MRC Vitamin Study Research Group, 1991; Czeizel & Dudas 1992; Bower, 1995; James et al, 1999) . Adequate folate status lowers the risk of disturbances in the early stage of embryonal development. Particularly important is periconceptional intake of folate before the neurulation process is initiated and completed. The epidemiological studies suggest that up to 70% of NTDs can be prevented by increased folate intake.
The deficiency of the antioxidant vitamins predisposes to the development of chronic diseases, including coronary heart disease, hypertension, stroke and many types of cancer. Folates are also important factors in homocysteine metabolism, which is an independent risk factor for coronary, cerebral and peripheral atherosclerosis (Clarke et al, 1991; Verhoef et al, 1996 Verhoef et al, , 1998 Moghadasian et al, 1997; Stampfer, 1997) . Higher than average homocysteine levels have been reported in women with NTD pregnancies (Steegers-Theumissen et al, 1991) . Many data provide evidence that higher intake of folates or supplementation with folate alone or together with vitamin B 12 and vitamin B 6 can reduce elevated plasma homocysteine level (Ubbink et al, 1993; Selhub et al, 1993; Dierkes et al, 1996; Pietrzik and Brönstrup, 1997b; Ward et al, 1997; Woodside et al, 1998; Brouwer et al, 1999; Mann et al, 1999) .
Poland belongs to the group of countries with highest incidence and mortality due congenital anomalies (Lech et al, 1997) . Taking into account the role folates, vitamin B 12 and antioxidant vitamins play in preventing different diseases, there is a need to monitoring vitamin status of subpopulations. The aim of this study was to measure the nutritional vitamin status and the risk of hyperhomocysteinaemia in the group of healthy women of childbearing age. There is a lack of information in our country about the nutritional vitamin status and serum tHcy concentrations in this age group of women.
Subjects and methods
The sample comprised 78 healthy female inhabitants of Warsaw aged 18 -30 y. Volunteers were recruited from high school students, laboratory staff and staff family members. Approval for the study was obtained from the Ethics Committee of the Institute of Food and Nutrition. The subjects gave informed consent before being admitted into the study. Women who were or had been pregnant or were taking drugs were excluded because of confounding effects on blood folate values and other indices. Information was taken about age, health status and use of oral vitamin supplements.
Fasting peripheral blood samples were collected by venipuncture by trained personnel in the period from September 1998 to March 1999. The samples of EDTAcontaining whole blood were used to measure haemoglobin, haematocrit and RBC folate concentration. Whole blood not containing anticoagulant was separated by centrifugation to obtain serum for folate, antioxidant vitamins, vitamin B 12 and homocysteine level analysis. Serum samples for folate determinations were immediately treated with phosphate buffer containing 200 mg% of ascorbic acid and after protein precipitation stored at 770 C until analysis. To determine folate content in red cells, blood samples with EDTA were haemolysed in distilled water containing 1 g% of ascorbic acid. Serum samples for tocopherol, retinol, carotenoids and total homocysteine determinations were stored at 770 C until analysis. Aliquots for ascorbic acid determinations were immediately treated with fresh trichloroacetic solution and frozen at 770 C. Haemoglobin and haematocrit assessment was done using the instrument Hycel-1020. Serum folate concentrations were determined by Herbert (1961) microbiological method, ascorbic acid, tocopherol, retinol and carotenoids by spectrophotometric methods (Hashim & Schuttringer, 1996; Bessey et al, 1990; Lowry et al, 1945) . Serum vitamin B 12 concentrations were measured by the radioimmunological method using vitamin B 12 -folate dual RIA kit (Kodak Clinical Diagnostic Ltd). RBC folate concentrations were assessed by Hoffbrand et al (1996) method. Serum total homocysteine concentrations (tHcy) were determined by HPLC according to the technique of Araki and Sako (1987) modified by Ubbink et al (1991) .
The results are given as means and standard deviations. The adequacy of vitamin nutritional status is based on cutoffs for defining high, moderate, low risk and cut-offs for the optimal concentrations preventing chronic diseases (Lewis et al, 1992; Gey, 1994; Kang et al, 1992) .
Results and discussion
The mean age of women was 24.7 y (18 -30 y). About 12% of women of childbearing age were taking tocopherol, retinol and some vitamin B group supplements from different vitamin preparations. Folic acid in the form of multivitamin or multivitamin -mineral preparations was taken by 14 women sporadically in different doses and in amounts which comprised 7.5% of the mean total folate intake of the group. Vitamin C supplements were taken by 34% of all persons in the group.
The measurements of haematological indices showed that all studied women had haemoglobin and haematocrit concentrations in the range of normal values according to WHO criteria. Table 1 presents the results of serum vitamin and total homocysteine determinations in the group of women of childbearing age. The mean serum folate concentration, 6.8 ng=ml (2.0 -20.0 ng=ml), and mean RBC folate value, 185.5 ng=ml (52 -274 ng=ml) of the studied women were similar to those in American women of the same age (Report of Food and Nutrition Board, 1998) and in Brouwer et al,'s (1999) investigation. RBC folate in our study was lower than in study conducted in Denmark (Rasmussen et al, 2000) . The mean serum vitamin B 12 concentration in the studied women of childbearing age 359.9 pg=ml (200 -611 pg=ml) was lower compared to the value 443 pg=ml (203 -978 pg=ml) in German women (Rauh et al, 1999) (Rauh et al, 1999) and close to the value of 7.6 mmol=l (Rasmussen et al, 2000) . In Wageningen, in healthy non-pregnant women aged 18 -40 y mean serum total homocysteine concentration was 10.4 AE 2.4 mmol=l (Brouwer et al, 1999) . In our study the concentration of serum tHcy was inversely linearly correlated with serum and RBC folate concentration (r ¼ 70.455, r ¼ 70.583) in the group of women with low folate status (serum folate <13.6 nmol=l, RBC folate <340 nmol=l). In the group of women with serum tHcy <5.0 mmol=l mean serum folate concentration was higher (15.8 AE 7.2 mmol=l) in comparison with tHcy group, >5 mmol=l (P<0.001). It seems that for normalisation of homocysteine concentration acceptable serum folate should be higher than 15.8 nmol=l.
The distribution of serum total homocysteine concentration in the studied group of women of childbearing age is shown in Table 2 . Different cut-off values are used by investigators to define elevated homocysteine levels. According to the classification of Kang et al, (1992) , none of the women under study had serum total homocysteine concentration >15 mmol=l, indicating hyperhomocysteinaemia. In Rauh et al, (1999) study hyperhomocysteinaemia >15 mmol=l occurred in 7% of adult women.
Observational studies indicate that folate deficiency, homocysteine metabolic defects and homozygosity for the metylenotetrahydrofolate reductase termolabile variant are probable risk factors of placental abruption, preeclampsia, premature delivery, reccurent abortions and neural tube defects (Ray & Laskin, 1999) . In the Hordaland Homocysteine Study (Vollset et al, 2000) , conducted in women, different relations were observed between plasma tHcy and various pregnancy complications. The excess risk for placental abruption was confined to women with tHcy concentrations >15 mmol=l. Malformations and preeclampsia were related to the central distribution of tHcy (5 -15 mmol=l). In our study serum tHcy in the range 5 -15 mmol=l was found in 71.8% of the group. The total homocysteine values were higher than 10 mmol=l, which in the opinion of the American Heart Association of Experts (Malinow et al, 1999) indicates the need to take increased amounts of folate, vitamin B 12 and vitamin B 6 were found in 7.7% of the studied group of women. Deficiencies of vitamin B 12 or vitamin B 6 cause homocysteine to accumulate and elevate serum concentration.
The incidence of vitamin deficiency risks is presented in Table 3 according to the cut-off points given in Table 4 . Based on the cut-off levels for optimal health proposed by Gey (1994) the optimal serum tocopherol concentrations preventing chronic disease were found in 5.5% and the optimal serum retinol concentrations in 6.4% of the studied group. A moderate degree of tocopherol risk was found in 10.9% and a low risk in 83.6% of all persons. There was no high or moderate deficiency risk for ascorbic acid and vitamin B 12 . A low degree risk of ascorbic acid was found in 5.2% and vitamin B 12 in 38.2% of the studied. Almost all women of childbearing age under study (94.8%) had optimal serum ascorbic acid; 34% of total persons were taking vitamin C supplements. According to criteria presented in Table 4 , optimal serum folate concentrations (>14.9 nmol=l) were found only in 32%, high-risk deficiency (<6,8 nmol=l) in 6.4% and moderate=low risk in 61.6% of the total group. RBC folate concentration are the indicators of long-term folate status and hence the body stores. Adequate folate body stores (>680 nmol=l) were found in only 1.5%, high-risk depletion (<340 nmol=l) in 28.8%, and moderate=low risk in 69.7% of all studied persons. In recent years the inverse relationship between certain diseases and serum antioxidant vitamins level has led to the recommendation of optimal serum levels considerably higher than those only preventing deficiency risk, in the evaluation of nutritional vitamin status. In a nutrition survey conducted in France (Costa de Carvalho et al, 1996) folate deficiency (serum 6.8 -13.6 nmol=l) was found in about 30% of women aged 18 -29 y. In The Netherlands (Brussaard et al, 1997) , prevalence of serum concentrations below 7 nmol=l in group of women aged 20 -40 y was 13%. In our earlier studies (1984 -1989) we found risk of folate deficiency (<13.6 nmol=l) in 71% of Warsaw school children, in 49% of pregnant women, and in 65% of obese and overweight women of different ages (Wartanowicz & Ziemlański, 1990; Moor de Burgos et al, 1992) . In the screening analysis of nutritional status conducted in 1992 and 1996 y in persons with ischaemic heart disease the prevalence of folate risk (<13.6 nmol=l) was about 50% (Wartanowicz et al, 1998) . Rogalska-Niedźwiedź et al (2000) assessed daily folate intake of the group of women of childbearing age. They found mean daily folate intake with supplements in the range 111 -1265 mg (mean 341AE 153 mg). Nearly 80% of women of childbearing age did not meet the 400 mg folate value actually recommended.
Recent evidence has confirmed the importance of adequate folate intake not only to reduce risk of neural tube defects but also atherosclerotic disease and carcinogenic processes (Butterworth et al, 1992a,b; Giovannuci et al, 1993; Kirke et al, 1993; Giles et al, 1995; Kim, 1999; Verhoef et al, 1998; Voultainen et al, 2000; Ziegler et al, 1990) . The strongest evidence exists for colorectal cancer. The maintenance of adequate folate status is suggested also to reduce the risk of pancreatic cancer in male smokers and breast cancer in women regularly consuming moderate amounts of alcohol (Nutr. Rev. 1999, 10). The potential mechanism for folate deficiency-related enhancement of carcinogenesis may be DNA hypomethylation, increased chromosomal fragility, diminished DNA repair or facilitation of tumorigenic virus metabolism. Suboptimal folate status may predispose to cellular dysplasia and cancerous lessions in the epithelium of cervix and colorectum. In clinical trials the subjects with human papilloma virus cervical neoplasm infection had a several-fold greater risk of having dysplasia if they also had diminished RBC folate level <680 nmol=l (Reeves et al, 1989) . Even a moderate reduction of folate status within the range of conventionally accepted levels of intake increased the risk for developing dysplasia From Daly et al, (1995) investigation, the lowest risk of NTD in infants occurs when the mothers folate RBC levels are higher than 906 nmol=l. The evidence of the protective effect of folate supplementation on NTD led in the USA to the issuing of a regulation for fortification of flour and cereals with folic acid, effective in 1998.
Conclusion
The results of the presented study showed insufficient vitamin status of women in childbearing age, mainly folate status. Suboptimal serum folate levels were found in 68% and suboptimal folate body stores (>680 nmol=l) were present in 98% of women studied. Taking into account the health danger resulting from insufficient vitamin and particularly folate intake, there is a need for further investigation of folate status of young women in a larger population sample and development of an intervention strategy, by promoting increased vegetable, fruit and whole grain consumption and advising the use of folic acid supplements by women who intend to become pregnant. The results of the study and earlier ones suggest also the necessity of food fortification with folic acid in our country.
